Gabelli & Co Investment Advisers’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-7,850	Closed	-$713K	–	167
2017 Q2	$713K	Sell	7,850 -17,600	-69%	-$1.6M	0.08%	96
2017 Q1	$2.23M	Buy	+25,450	New	+$2.23M	0.25%	57